[SELECT trial] Metabolic dysfunction-associated steatohepatitis (MASH) (adults) For the treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH), formerly known as nonalcoholic steatohepatitis (NASH), with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis) in adults
Surender Kumar has been advisory board member of Boehringer Ingelheim India, Astra Zeneca, Jansen, Novo Nordisk, Eli Lilly, MSD, Sanofi-Aventis, USV Private Limited, Eris Lifesciences, Lupin Limited, and Roche Diabetes Care India Pvt
Autism spectrum disorders : Emerging research suggests that glutathione can help reduce oxidative stress in individuals with autism
922-6 [online] Available at: Lindschinger, M., Tatzber, F., Schimetta, W., Schmid, I., Lindschinger, B., Cvirn, G., Stanger, O., Lamont, E